Purchase Order HT940623P0089

Award Date 5/3/23
Potential Completion Date 7/31/24
Potential Value $16K
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Goose Creek, SC 29445, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $199,744.50, is for a standard service agreement for Cepheid's GeneXpert system. The contract has an ultimate completion date of December 10, 2026. Cepheid is the prime contractor and there is no set-aside designation for this award. Cepheid has previously received numerous federal contract and grant awards from agencies...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a Laboratory Cepheid GeneXpert Service Agreement. The $103,975.00 contract has a period of performance through June 18, 2028 and does not have a set-aside designation. Cepheid has received numerous prime federal contracts to provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to...
This is a $133,347.84 firm fixed price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for GeneXpert service and maintenance, with a period of performance through March 6, 2026. The original solicitation requested pricing for the provision of these services, without any set-aside designation. Cepheid is a leading provider of molecular diagnostic systems and tests to federal agencies, including the...
The Defense Health Agency has awarded a firm-fixed-price purchase order to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a GeneXpert IV Service Agreement plus four option years. The contract, valued at $36,197.21, will provide GeneXpert diagnostic equipment, reagents, consumables, and maintenance services to support clinical testing programs for the agency. Cepheid is the prime contractor and original equipment manufacturer, and the contract does not have a...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $101,475.00, is for the provision of CEPHEID SERVICE and has an ultimate completion date of July 31, 2028. The contract does not have a set-aside designation. Cepheid, the prime contractor, is an experienced federal contractor, having been awarded numerous prime contracts and subcontracts to provide diagnostic testing...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for $13,000.50 to provide maintenance service for GeneXpert diagnostic equipment. The contract has an ultimate completion date of April 17, 2025. Cepheid is a leading provider of diagnostic equipment, reagents, and support services to federal agencies, including the Department of Veterans Affairs (VA) and Department of Health and Human...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide annual maintenance services for GeneXpert diagnostic systems. The $161,500.00 contract has a completion date of August 28, 2027 and does not have a set-aside designation. Cepheid has received numerous other federal contract awards and grants to supply the Department of Veterans Affairs, the Defense Logistics Agency, and the...
This is a firm fixed price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide equipment maintenance and support services. The contract has a ceiling value of $139,197.26 and a period of performance through September 19, 2025. The original solicitation was a special notice that did not use a small business set-aside. Cepheid has previously received numerous prime federal contracts and subcontracts from agencies...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract was awarded by the Defense Logistics Agency, an agency of the U.S. Department of Defense, and has a ceiling value of $6,120.00. The contract is a delivery order with a firm fixed price pricing type, and the ultimate completion date is February 6, 2025. The...
The Department of Defense (DoD) Defense Health Agency awarded a firm fixed-price purchase order to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, for the provision of two GeneXpert XVI molecular diagnostic systems. The $173,400.00 contract has an ultimate completion date of September 10, 2024 and does not utilize any set-aside designations. Cepheid is an original equipment manufacturer and prime contractor that specializes in advanced diagnostic systems and test...

This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a service agreement to provide GeneXpert diagnostic equipment, reagents, consumables, and associated maintenance and support services. The contract has a ceiling value of $16,492.68 and a performance period ending on July 31, 2024. Cepheid has been awarded numerous prime federal contracts and indefinite-delivery vehicles (IDVs) with various government agencies, including the Department of Veterans Affairs, to deliver its molecular diagnostic solutions in support of clinical testing programs. This particular contract does not have a set-aside designation.

Generated 4/2/25, 9:56 AM